biology of incretins glp 1 and gip Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release are used to treat type 2 diabetes mellitus and #obesity. GLP-1 receptor agonists and GLP-1 and glucose-dependent insulinotropic Gastrointestinal Incretins—Glucose-Dependent Insulinotropic Polypeptide (GIP)

Our findings show that SGLT2 inhibitors appear more effective in reducing cardiovascular events in older people, and this may be one piece of information that clinicians can take into account when deciding with individual patients what is best for them. Our findings also suggest that clinicians should not be put off by smaller changes in blood sugar in older people, as the cardiovascular benefits were greater despite a smaller improvement in blood sugar, he added.

How compounded semaglutide compares All prescriptions are at the discretion of a medical provider

By Sonia Garcia | May 23, 2025 Stress can push the brain to its limits, sometimes distorting perception and creating sensory experiences that feel real but arent

Chronic constipation, low fiber intake over years, and obesity are risk factors, but a specific food event doesnt always cause the attack immediately